Tempest Therapeutics, Inc. (TPST) KPIs and segments

TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/30

$0.38−0.01 (-3.53%)

Close on Nov 12, 2026Market cap $5.67MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Tempest Therapeutics's business

Coming soon

This tab will track the numbers specific to Tempest Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?